The present invention provides a nonostructured device comprising a substrate including nanotroughs therein; and a lipid bilayer suspended on or supported in the substrate. A separation method is also provided comprising the steps of supporting or suspending a lipid bilayer on a substrate; wherein the subtrate comprises nanostructures and wherein the lipid bilayer comprises at least one membrane associated biomolecule; and applying a driving force to the lipid bilayer to separate the membrane associated biomolecule from the lipid bilayer and to drive the membrane associated biomolecule into the nanostructures. A fluidic device for separating particles according to size is provided including a fluidic channel, and a matrix comprising a plurality of protrusions within the fluidic channel, wherein the device provides a driving force to the particles being separated through the fluidic channel; and wherein a flow of the driving force from between the protrusions is divided unequally into a major flow component and a minor flow component, each component flowing between subsequent protrusions in the matrix, such that the average direction of the major flow component is not parallel to the average direction of the driving force, and, when particles are introduced into the matrix, particles having a size less than a predetermined critical size are transported generally in the average direction of the driving force, and particles having a size at least that of the critical size are transported generally in the average direction of the major flow component, thereby separating the particles according to size. Methods for separating particles including steps of separation based on size and affinity are also provided.

Patent
   RE42249
Priority
Feb 14 2001
Filed
Jul 01 2008
Issued
Mar 29 2011
Expiry
Feb 14 2022

TERM.DISCL.
Assg.orig
Entity
unknown
15
235
EXPIRED
0. 38. A method for separating particles comprising:
(a) providing a substrate and an array of structures arranged on said substrate, wherein said structures comprise protrusions fixed to said substrate in a predetermined pattern having a gradient property in a given direction across a plane of said substrate;
(b) a first separation step comprising separating said particles by size in two dimensions by flowing said particles through said array of structures in said given direction, the separating of said particles occurring at least in part by virtue of said pattern; and
(c) a second separation step comprising separating said particles by affinity.
0. 1. A nanostructured device comprising:
a substrate including at least one nanotrough therein; and
a lipid bilayer suspended over said at least one nanotrough.
0. 2. The nanostructured device of claim 1, wherein said lipid bilayer comprises a simple bilayer.
0. 3. The nanostructured device of claim 1, wherein said lipid bilayer comprises a hybrid bilayer.
0. 4. The nanostructured device of claim 3, wherein said hybrid bilayer comprises a self-assembled monolayer hybrid bilayer.
0. 5. The nanostructured device of claim 1, wherein said at least one nanotrough is filled with at least one fluid.
0. 6. The nanostructured device of claim 1, wherein said nanostructured device further comprises an array of nanostructures arranged so that said array has a gradient property.
0. 7. The nanostructured device of claim 1, wherein said nanostructured device further comprises at least one nanostructured channel.
0. 8. The nanostructured device of claim 1, wherein said substrate comprises Si.
0. 9. The nanostructured device of claim 1, wherein said substrate comprises a semiconductor chip.
0. 10. The nanostructured device of claim 1, wherein said nanostructured device comprises a biochip.
0. 11. A nanostructured device comprising:
a substrate including at least one nanotrough therein; and
at least one lipid bilayer supported in at least one of said at least one nanotroughs so as to allow biomolecules to pass from said at least one lipid bilayer into said at least one respective nanotrough.
0. 12. The nanostructured device of claim 11, wherein said lipid bilayer comprises a simple bilayer.
0. 13. The nanostructured device of claim 11, wherein said lipid bilayer comprises a hybrid bilayer.
0. 14. The nanostructured device of claim 13, wherein said hybrid bilayer comprises a self-assembled monolayer hybrid bilayer.
0. 15. The nanostructured device of claim 11, wherein said nanostructured device further comprises an array of nanostructures arranged so that said array has a gradient property.
0. 16. The nanostructured device of claim 11, wherein said nanostructured device further comprises at least one nanostructured channel.
0. 17. The nanostructured device of claim 11, wherein said substrate comprises Si.
0. 18. The nanostructured device of claim 11, wherein said substrate comprises a semiconductor chip.
0. 19. The nanostructured device of claim 11, wherein said nanostructured device comprises a biochip.
0. 20. A separation method comprising the steps of:
(a) supporting or suspending a lipid bilayer on a substrate; wherein said substrate comprises at least one nanostructure and wherein said lipid bilayer comprises at least one membrane associated biomolecule; and
(b) applying a driving force to said lipid bilayer to separate said at least one membrane associate biomolecule from said lipid bilayer and to drive said at least one membrane associated biomolecule within said lipid bilayer into said at least one nanostructure.
0. 21. The method of claim 20, wherein said at least one nanostructure comprises at least one nanotrough.
0. 22. The method of claim 21, wherein said at least one nanotrough is filled with at least one fluid.
0. 23. The method of claim 20, wherein said at least one nanostructure comprises at least one channel.
0. 24. The method of claim 20, wherein said at least one nanostructure further comprises at least one protrusion.
0. 25. The method of claim 20, wherein said substrate comprises Si.
0. 26. The method of claim 20, wherein said lipid bilayer comprises a simple bilayer.
0. 27. The method of claim 20, wherein said lipid bilayer comprises a hybrid bilayer.
0. 28. The method of claim 27, wherein said hybrid bilayer comprises a self-assembled monolayer hybrid bilayer.
0. 29. The method of claim 20, wherein said at least one nanostructure comprises an array of nanostructures arranged so that said array has a gradient property.
0. 30. The method of claim 20, wherein said at least one membrane associated biomolecule comprises a transmembrane protein.
0. 31. The method of claim 20, wherein said at least one membrane associated biomolecule comprises a membrane phospholipid.
0. 32. The method of claim 20, wherein said at least one membrane associated biomolecule comprises a lipophilic biomolecule.
0. 33. The method of claim 20, wherein said driving force comprises electrophoresis.
0. 34. The method of claim 20, wherein said driving force comprises an externally applied pressure.
0. 35. The method of claim 20, wherein said driving force comprises capillarity.
0. 36. The method of claim 20, wherein said driving force comprises diffusion.
0. 37. The method of claim 20, wherein said driving force comprises osmosis.
0. 39. The method of claim 38, wherein said separation based on affinity comprises affinity chromatography.
0. 40. The method of claim 39, wherein said separation based on affinity chromatography comprises immunoaffinity.
0. 41. The method of claim 38, wherein said gradient property is discrete.
0. 42. The method of claim 38, wherein said structures create at least one channel.
0. 43. The method of claim 38, wherein said substrate comprises Si.
0. 44. The method of claim 38, wherein said substrate comprises silicon carbide.
0. 45. The method of claim 38, wherein said particles are biomolecules.
0. 46. The method of claim 38, wherein separating particles further comprises an additional separation step based on a mechanism selected from the group consisting of size exclusion, asymmetric diffusion, entropic trapping and hydrophobic interaction.
0. 47. The method of claim 38, wherein said structures are surface modified.
0. 48. The method of claim 47, wherein said surface modification comprises modification with poly-ethylene glycol.
0. 49. The method of claim 47, wherein said surface modification comprises modification with one or more oligonucleotide probes.
0. 50. The method of claim 47, wherein said surface modification comprises modification with a hydrophobic molecular or oligomeric species.
0. 51. The method of claim 47, wherein said surface modification comprises modification with a chiral selector selected from the group consisting of cyclodextrins, macrocyclic antibiotics and crown ethers.
0. 52. The method of claim 38, wherein separating particles further comprises applying a driving force to induce said flowing of particles.
0. 53. The method of claim 52, wherein said driving force comprises externally applied pressure.
0. 54. The method of claim 52, wherein said driving force comprises capillarity.
0. 55. The method of claim 52, wherein said driving force comprises diffusion.
0. 56. The method of claim 52, wherein said driving force comprises osmosis.

exentpolycrylamide polyacrylamide. The biomolecules in the mixture then migrate to the region where the pH is equal to a particular biomolecule's isoelectric point, at which time the charged biomolecule becomes electrically neutral. This technique, combined with subsequent separation by SDS-PAGE, is used in traditional two-dimensional gel electrophoresis. Similar pH gradients may be generated using an array of the present invention including a two-dimensional gradient, using traditional isolectric isoelectric focusing with soluble ampholytes or by using chemical patterning techniques, or immobilization of ampholytes after electrical focusing. Examples of capillary-based isoelectric focusing separation processes suitable for use with the present invention are described in Thorman, Tsai, Michaud, Mosher and Bier, Capillary Isoelectric-Focusing: Effects of Capillary, Geometry, Voltage Gradient and Addition of Linear Polymer, J. Chromatography, 398:75-86 (1987), the entire contents and disclosure of which are hereby incorporated by reference.

For the purposes of the present invention, the term “asymmetric diffusion separation process” refers to a separation process in which steric constraints drive diffusion preferentially in one direction. Examples of asymmetric diffusion separation processes suitable for use with the present invention are described in Van Oudenaarden et al., Science, 285: 1046-1052 (1999), the entire contents and disclosure of which are hereby incorporated by reference.

For the purposes of the present invention, the term “entropic trapping separation process” refers to separations using nanostructured devices of alternating thin and thick regions, with the thin regions being smaller than the radius of gyration of the biomolecule being separated. Under an electrical field, the molecules repeatedly change conformation, costing entropic free energy, thus limiting mobility. An example of an entropic trapping separation process suitable for use with the present invention is described in Han J, Craighead H D, Separation of long DNA molecules in a microfabricated entropic trap array, Science, 288:1026-1029 (2000), the entire contents and disclosure of which is hereby incorporated by reference.

For the purposes of the present invention, the term “hydrophobic interaction chromatography separation process” refers to a technique whereby molecules are partitioned between a hydrophobic matrix and a hydrophilic solvent. The degree of hydrophobicity of the target molecule determines the target molecule's retention time. The array of the present invention may be modified to incorporate a gradient of hydrophobicities or to create a milieu in which the hydrophobicity may be rapidly and reversibly changed, thus providing a driving force for molecular movement.

For the purposes of the present invention, the term “affinity chromatography separation process” refers to a chromatography process that takes advantage of specific chemical interactions between a target molecule and a chromatographic matrix. One of the most widely used forms of affinity chromatography employs immunoaffinity in which an antibody or series of antibodies are immobilized on a support. Other affinity agents include enzymes that interact with specific targets or receptors. Another example of affinity chromatography is a molecular recognition separation process such as the separation of long DNA molecules in a microfabricated entropic trap array. An array of the present invention may be used for both the generation of affinity matrices and for the subsequent use of affinity matrices.

For the purposes of the present invention, the term “enantiomeric resolution separation process” refers to a process to separate organic particles, such as biomolecules by chirality. Enantiomeric resolution is especially important in carbohydrate separations where differences between different glycosides are exclusively enantiomeric. Indeed, common chiral selectors are cyclodextrins used in capillary electrophoresis. Macrocyclic antibiotics and crown ethers are commonly used selectors. Selectors may be used either globally or in zones of an array of the present invention to confer yet another means of separation.

For the purposes of the present invention, the term “capillary electrophoresis separation process” refers to a separation process in which separation takes place in a liquid rather than in a gel matrix. Capillary electrophoresis allows for separations to be done on smaller quantities of material and with improved resolution in comparison to conventional gel electrophoresis processes. The channels in an array of the present invention may be arranged to generate a capillary type arrangement in a second direction following separations based on chemical properties (e.g., IEF, affinity, hydrophobic interaction chromatography or enantiomeric separation) or capillaries may be applied as a third dimension.

For the purposes of the present invention, the phrase “comprises Si” refers to silicon and any silicon complex, compound, etc. that includes silicon, such as SiO2, glass, etc.

For the purposes of the present invention, the term “lipid” refers to conventional lipids, phospholipids, etc.

For the purposes of the present invention, the term “lipid bilayer” refers to any double layer of oriented amphipathic lipid molecules in which the hydrocarbon tails face inward to form a continous continuous nonpolar phase.

For the purposes of the present invention, the term “simple bilayer” refers to a conventional lipid bilayer in which the bilayer is formed from micelles of phospholipids with or without membrane proteins.

For the purposes of the present invention, the term “hybrid bilayer” refers to a bilayer that is derived from more than one source, either through mixing of micelles before formation, or post bilayer fusion. These also refer to bilayers in which one component is synthetically derived, or in which one leaflet is supported on the nanotextured surface prior to bilayer formation.

For the purposes of the present invention, the term “self-assembled monolayer hybrid bilayer” refers to a hybrid bilayer in which the synthetic portion is composed of a self-assembled monolayer of silanes or ω-substituted alkanethilates on gold.

For the purposes of the present invention, the term “suspended” refers to bilayers present on a nanostructure and located above nanotroughs in a nanostructure. An example of a suspended bilayer is shown in FIGS. 9, 10 and 11.

For the purposes of the present invention, the term “supported” refers to bilayers located in nanotroughs of a nanostructure. An example of a supported bilayer is shown in FIG. 12.

For the purposes of the present invention, the term “nanotrough” refers to a trough with a void dimension of 1-500 nm, whether uniform or not.

For the purposes of the present invention, the term “leaflet” refers to one half of a fluid bilayer membrane composed of a single layer of phospholipids and any included proteins.

For the purposes of the present invention, the term “filled with at least one fluid” refers to a nanostructure, preferably a nanotrough or channel, containing a fluid that is at least partially contained within said nanostructure. The nanostructure does not need to be completely filled with a fluid according to this definition.

For the purposes of the present invention, the term “membrane associated biomolecule” refers to any membrane associated biomolecule, such as transmembrane proteins, membrane phospholipids, lipophilic biomolecules, complexes thereof, etc.

The present invention provides, in part, for robust, inexpensive and reproducible methods for forming separation matrices for gradient separations based on, for example, electrophoresis and size exclusion that includes all the positive traits of gradient PAGE. These matrices may be adapted for a host of variant separation strategies, including electrophoresis, detergent solubilization, native electrophoresis, isoelectric focusing, 2D-electrophoresis, hydrophobic interaction, and affinity chromatography. More specifically, the present invention provides for the use of such separation matrices as support for lipid bilayers that serve as separation platforms for membrane-associated biomolecules. The methods of fabrication discussed herein may also be adapted to existing microfabrication and integration facilities.

The present invention provides for separation of molecular species across a nanostructured matrix, a method of fabricating nanostructures comprising the matrix and the use of such a matrix for separation and/or analysis of molecules by defining the physical size and/or chemical features of the nanostructures as a means of screening. The nanostructured matrix may be used to separate biological materials, such as proteins, carbohydrates, and nucleic acids as well as non-biological materials, such as synthetic polymers. These nanostructures may be made out of a variety of materials, including silicon, thus providing systems that may be easily chemically modified for additional flexibility. The use of lithography to generate nanostructured separation matrices has advantages over other techniques (such as traditional acrylamide gel polymerization) since it (1) creates highly ordered structures, (2) gives the possibility of creating macroscopic arrays of continually varying size or chemistry across one dimension, (3) is highly reproducible, and (4) may be easily implemented in the creation of complex, integrated separation systems that are disposable or reusable. Furthermore, the use of lithographically defined separation matrices lends itself to the facile implementation of these matrices into multi-level, 3-dimensional separation devices in which different screening mechanisms allow enhanced separations. Particularly, the lithographic nanostructured surfaces may be used to support lipid bilayers or hybrid lipid bilayers for separating membrane-associated molecules and studying cellular interactions. The present invention aims to (1) eliminate some of the current limitations by the fabrication of highly uniform and reproducible nanostructured separation systems prepared by nano- and microlithography, and (2) eliminate some of the current limitations by utilizing the lithographic nanostructured surfaces in conjunction with lipid bilayers to produce separation platforms for membrane-associated molecules.

Nanolithographically-Defined Gradients:

Using an advanced lithographic technique such as interferometric lithography (IL) capable of producing nanostructures, patterns of nanostructures may be rapidly created over wide, macroscopic areas at low cost (compared to other techniques such as electron beam lithography). In addition, it may be used to easily generate arrays of nanostructures (protrusions or channels) whose dimensions vary semi-continuously in the plane of surface of the material being patterned. IL has advantages over other methods that might be used to construct nanopatterned fluidic structures (e.g., electron beam lithography, X-ray lithography, or local probe lithography) due to the low cost of implementation and the parallel nature of the lithographic technique. Combining IL with conventional lithography allows for the formation of device structures in individual areas and the addition of aperiodic features such as electronic and fluidic connections. Imaging interferometric lithography extends optics to fundamental, deep-subwavelength scales.

It is worthwhile at this point to consider the fundamental limits of optical lithography. For the interference of two plane waves in air, the period is given by λ/(2 sin θ) where λ is the optical wavelength and θ is the angle of incidence. For a 213-nm laser source (fifth harmonic of YAG) this gives a period of ˜150 nm (for θ=80°). FIG. 1 shows an example of a large-area, 150 nm period, photoresist grating. It is important to realize that this limit is on the period, not on the feature dimensions. Nonlinearities in the exposure/develop processes and in subsequent processing may reduce the feature to dimensions well below λ/4. An example in FIG. 2 shows 30-nm developed resist lines on a 360-nm pitch written at a wavelength of 364 nm. The ultimate limit in linewidth is set by material properties and by uniformity of the processing; linewidths as small as 10 nm are routinely achieved. The use of immersion techniques may further reduce the period by a factor of the refractive index, approximately a factor of 1.5, to a period of ˜75 nm. Initial results reproduced the 150 nm pitch of FIG. 1 at a lower angle of incidence.

Water and higher-index liquids, including liquid Ar (n˜1.6), may be used to further extend these results into the sub-100-nm period regime that will be important for biological separations. FIG. 3 shows an initial example of immersion interferometric lithography where the grating period has been reduced to 108 nm with exposure by 213 nm light using immersion in deionized water.

Nonlinear processes may be used to further reduce the period. FIG. 4 shows an example of a photoresist line interpolated between two parallel lines that have already been transferred into a nitride layer. FIG. 5B shows the result of transferring both of these patterns into Si using a KOH etch process. The final period is ˜half of the initial IL period. Extending the calculation above with this spatial period division gives a period of ˜37 nm and a dense linewidth of ˜17 nm (λ/12).

Importantly, all of these results are macroscopic in scale, e.g., covering areas of ˜1 cm2 or larger. A strength of optics is the parallel nature of the exposure, which may be cm's or larger in extent. For a square lattice with a 100-nm pitch and a 1 cm field, there are 1010 features, well beyond the realistic capabilities of serial techniques such as e-beam and scanning probes. In particular embodiments of the present invention, IL may be extended deep into the nanometer regime (either to feature sizes of ˜10 nm or nearest-neighbor distances (aperture sizes) of <10 nm, but not both simultaneously).

A continuously varying channel spacing between nanostructures is desired for many of the bio-separation applications such as various nanofluidic configurations discussed herein.

One approach to a graded structure is to macroscopically vary the intensity across the plane of exposure while keeping the other interference conditions, such as the angles between the light propagation vectors and the polarization, unchanged. One such variation of intensity would be a smooth gradient in intensity of one of the two interfering light waves. This results in interference fringes with uniform spacing but different intensities. The difference in intensity of the fringes leads to differences in exposure of the photoresist used. Because the fringe spacing is not changed, the pitch is uniform. The interference pattern would have even better contrast if both light waves had the same gradient in intensities.

When a positive photoresist is used, the areas corresponding to fringes with stronger intensities leave wider cavities in the photoresist after exposure and developing. The areas corresponding to fringes with weaker intensities leave narrower cavities in the photoresist. When the substrate is etched, these differing widths translate into features in the substrate that have differing widths. The features have the same pitch, however, because the fringe spacing is not altered. This leads to a constant pitch, but a varying line:space ratio. This procedure provides a continuously decreasing channel width that may be accurately controlled over very long distances. Such gradient separation matrices exhibit the favorable traits of gradient gels (high resolution in separation), without the difficulty and irreproducibility associated with their preparation.

Similarly, this technique, when used with a negative photoresist, leaves wider features in the areas corresponding to fringes with weaker intensity and narrower features in the areas corresponding to fringes with stronger intensity.

An alternative approach may produce features with a gradient in width and pitch. This may be easily achieved with IL by using a cylindrical lens in one of the beams, while keeping the other beam as a plane wave. In this case the plane of exposure becomes a chord for a number of circular wavefronts. Because the wavefronts have different radii of curvature (spacing of an optical wavelength), the spacing between the interference fringes, as well as the width of the interference fringes, vary along the length of the plane containing the interference fringes on the surface of the photoresist coating the substrate. Similarly, curved surfaces (sections of Newton's rings) may be formed by interfering a plane wave and a spherical wave or two spherical waves of differing radii of curvature.

Other types of separation systems may involve discontinuous gradients. One such system may have differing aperture sizes that may be produced by separate exposures with different intensities, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars in certain areas of a previously exposed uniform nano-structured surface.

Variations in size may also be produced chemically. For example, increasing the oxidation of silicon in certain areas of a chip may result in a swelling of the features, reducing the width of some channels while conserving the pitch of the features. Similarly, macroscopic areas may be selectively functionalized with monolayers, reducing the width of channels in that area.

One may also electrochemically produce silicon carbide on a silicon substrate. Silicon carbide is suitable for sublimation growth, allowing one to control the width of the modified channels in a certain area. Of course, silicon carbide is only one example of surface modifications that may be performed.

One may also selectively heat a substrate, bringing it close to its annealing temperature. At this time the substrate may be placed under a highly controlled stress. The subsequent strain alters the size of channels. A gradient in temperature across the substrate results in a gradient of strain, and therefore a gradient in channel widths. This technique would only be suitable for substrates without a crystalline structure (such as glass or amorphous silicon, for example).

The very high aspect ratios of FIGS. 5A and 5B were achieved using highly anisotropic wet chemical etching of crystalline Si in KOH, which exhibits a >400:1 etch-rate selectivity for etching the <100> plane relative to the <111> plane of Si. Thus, the vertical sidewalls are nearly perfect <111> Si facets. These structures may be further modified by oxidation. This provides insulation between the Si and the surrounding material (allowing electrophoretic fluidic manipulation) and varies the surface interactions between the nanostructure and the surrounding materials for fluidic applications. Very high aspect ratio, crystal-structure-independent etching processes have been developed to address the need for 3D structures in MEMs technology. These involve pulsed gas processes in which an isotropic etch process may be alternated with a surface passivation step to reduce the sidewall etch rate and only etch feature bottoms exposed by ion bombardment. To date, these processes have largely been investigated on micrometer scales. As part of the present invention, these processes are extended to the nanostructured regime. This greatly broadens the available classes of materials for which deep, high aspect ratio structures suitable for nanofluidic applications may be fabricated.

Nanostructures that exhibit a gradient in their capacity to transport biomolecular species (through size exclusion or otherwise) may be created by the IL processes discussed herein. Such gradients make separation matrices feasible for highly efficient separation of molecular species. Molecular species may be driven in the direction of the gradient, and thus separated based on their tendency to traverse the gradient, by a variety of driving forces, including, but not limited to, electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis.

IL represents a convenient method for generating nanostructured separation matrices that contain physical gradients that allow selective transport of chemical species and, thus, may be used to achieve a separation of different chemicals. When compared to other nanolithographic methods of pattern generation (e.g., electron beam lithography, scanning probe lithography), IL is more convenient, efficient and inexpensive because it may be used to generate the entire pattern in one, parallel step and is not a serial “writing” technique. Other parallel techniques (e.g., imprint lithography) rely on a primary patterning technique to generate a master that may then be used to produce replicas of nanostructured features in a parallel fashion. While IL is a preferred method to generate nanostructured gradients for molecular separation, a variety of methods could be employed to generate the nanostructured matrix gradient “artificial gels” of the present invention. Gradients in the chemistry of the separation matrix may be prepared by a variety of methods as well, including those based on IL.

The use of IL allows such nanostructured separation matrices to be produced easily and very inexpensively. Nanostructures in which channels are on the order of the excluded size of dissolved biomolecules allow an enhanced flexibility in separation. Higher resolution may be obtained in combination with any of the following mechanisms namely, size exclusion, electrophoretic mobility, isoelectric point, asymmetric diffusion, entropic trapping, hydrophobic interaction and affinity interaction (molecular recognition), as well as others. The gradient matrices produced allow efficient separation and identification of biomolecules such as native proteins and protein complexes in addition to denatured proteins and nucleic acids.

Nanolithography-generated systems have advantages over conventional systems in terms of (1) the virtually perfect uniformity of pore size and pore size distribution from device to device, and (2) the flexibility to precisely define the required distribution (gradient) of pore sizes and pore chemistries. This high degree of reproducibility and versatility in nanofabrication will result in the ability to construct separation devices that exhibit unprecedented degrees of flexibility (resolution, dynamic range) and reproducibility in their separation characteristics.

The separation gradient may be formed by a variety of means including, for example, nanolithography (e.g., IL, electron beam, local probe, nanoimprint) and pattern transfer (etching, deposition, lift-off) means.

FIG. 6 shows a schematic of a nanostructured gradient (chirped) separation matrix. The separation gradient may be formed by a variety of means including nanolithography (e.g., IL, electron beam, local probe, nanoimprint) and pattern transfer (etching, deposition, lift-off) means. FIG. 6 illustrates a graded array of nanostructures. The aperture size between the nanostructures approaches molecular dimensions. The arrows signify the direction of movement of molecular species comprising the mixture to be separated and the direction of separation. The height of the nanostructures is preferably sufficiently larger (e.g., 100 nm-1 μm) than the diameter to allow for higher throughput of the separated species.

Multiple-exposure IL moiré patterns provide for cyclic gradients that may be used for simultaneous manufacture of multiple structures. Gradients may also be fabricated across uniform patterns by non-uniform deposition or etching using properly designed deposition and/or etching tools and techniques such as oblique incidence of etch/deposition atomic/molecular species (shadowing). Analogous techniques may be used in generation of gradients in surface modification chemistry incorporated into the array.

FIGS. 7A and 7B show a perspective view and a top view, respectively, of a nanostructured matrix according to the present invention. Matrix 700 has a plurality of protrusions 702. A sample containing some concentration of molecules moves in the direction of arrow 704. The diameter of channel 705 between protrusion 706 and protrusion 708 is larger than the diameter of channel 709 between protrusions 710 and 712. This change provides a gradient such that larger molecules are inhibited from moving the entire length of matrix 700 once the molecules encounter channels between two protrusions that are smaller than the diameter of the molecule. FIGS. 7A and 7B may be extended to formation of channels to delineate the pathway for molecule movement.

As an example of channel formation according to the present invention, IL and anisotropic wet etching of Si allow the creation of open, parallel nanostructured channels (e.g., uncapped in the direction perpendicular to the surface) with lateral features on the order of biomolecular length scales (˜1-10 nm) but with overall dimensions reaching the microscopic (˜100 μm) or even macroscopic (˜1 cm or greater) scales. Depending upon the dimensions, molecular transport mechanisms may include diffusion, electrophoresis or bulk-flow. The relatively large vertical scale is sufficient to allow high throughput of molecules and external pumping using either electrokinetic or electro-osmotic forces. Examples of high aspect ratio IL nanostructured samples are shown in FIGS. 8A, 8B and 8C. Such architectures are applicable to channel and post arrays that are of interest for the separation of proteins and large DNA molecules.

Arrays of nanostructures (either of uniform size or with a gradient of sizes) may be surface-modified with chemical species that enhance the separation characteristics of the matrix. These chemical species may be distributed uniformly formly over the nanostructured separation matrix or may be distributed in a gradient (continuous or discrete) in the direction of separation over the matrix. These chemical species may include small organic molecules, polymers, receptors or other biomolecules.

IL may be used to expose patterns on photoresist on silicon or other materials (which may later be etched). Silicon and some other materials may have an oxide surface that is easily modified with silanization reagents. Synthetic strategies for modification are also available for other materials (besides oxides), including native silicon and noble metals (e.g., gold). Monomolecular layers may be created from a wide range of commercially- or synthetically-available chemical species that may enhance separation characteristics based on the type and degree of interaction of chemical species being separated with the walls of the surface-modified nanostructured separation matrix. Examples of types of surface modifications (either as gradients or uniform) include the use of hydrophilic oligomeric and polymeric species (e.g., poly-ethylene glycol (PEG)) to minimize interactions of chemical species, especially proteins, with nanostructured surfaces; use of hydrophobic molecular or oligomeric species to elicit hydrophobic interaction of chemical species (especially proteins) with nanostructured surfaces; use of mixtures of hydrophobic and hydrophilic species (polar, apolar, H-bonding, ionic) to tune interaction of different chemical species with surfaces; use of ionic molecular species and mixtures of ionic species to tune interaction of different chemical species with surfaces; use of biomolecular or organic receptors to elicit molecular recognition of small molecules, polymers, proteins, DNA, RNA, or oligonucleotides with the surface; use of oligonucleotide probes to tune interactions of DNA, RNA or nucleic-acid binding proteins with the surface; use of cyclodextrins, macrocyclic antibiotics, crown ethers and other chiral selectors to tune enantiomeric interactions of chemical species with the surface; and use of stimuli-responsive (smart) molecules or polymers to allow external control of interaction of chemical species with the nanostructured surface.

Other types of separation systems of the present invention may be thought of as having discontinuous gradients. These separation systems contain areas with different aperture sizes, and may be made either by separate exposures at different intensity, at different pitches through shadow masks, or by using multiple exposure techniques to eliminate rows and/or columns of pillars. Such systems are especially useful in that they will allow recovery of separated compounds (purification).

Microfabricated Integrated Multi-Dimensional, Multi-Technique Separation Systems

The present invention allows a variety of different separation strategies (electrophoresis, iso-electric focusing, affinity chromatography, hydrophobic interaction chromatography, enantiomeric resolution) to be used on a single monolithic device, thus allowing for ease of use and compactness of instrumentation.

The closest existing commonly used multi-technique separation is two-dimensional gel electrophoresis (2DGE). In traditional 2DGE, proteins are first separated according to isoelectric point, followed by resolution by mass-to-charge-ratio using standard polyacrylamide electrophoresis. This process requires that two separate electrophoretic procedures be performed, each requiring manipulation of the sample. A nanostructured matrix of the present invention allows for sequential analysis on a single chip, thus reducing sample loss and diffusion. The wide range of chemical modifications and array architecture allowed by IL devices will also permit separation of proteins by means in addition to size and isoelectric point, either by appropriate chemical patterning and valving of the device, or by addition of a third separation and/or dilution dimension.

Fabrication of separation matrix systems from materials (e.g., Si and quartz) commonly used in the fabrication of integrated circuits is advantageous. They have unique etching and surface modification characteristics that are well established, and may be easily implemented in existing microfabrication facilities for the development of complex separation and detection systems. Other materials with advantageous characteristics may also be used.

The nanostructured matrix of the present invention may be used for two-dimensional gel electrophoresis, and a number of other separation techniques may be combined with size exclusion and/or isoelectric focusing. In addition, the matrix has the capability of expansion beyond two dimensions.

Combining two or more standard types of analysis on a single platform may enhance the analytical potential of a nanostructured matrix of the present invention. Among the possible combinations of separation technologies applicable to this platform are those analogous to PAGE, isoelectric focusing, hydrophobic interaction chromatography, affinity chromatography, enantiomeric resolution and capillary electrophoresis. The matrix lends itself well to carrying out equivalent molecular weight separations, with either electrical currents or flow as the driving force.

The present invention may be useful in proteomics by enabling combinations of different types of analysis, e.g., size exclusion in one dimension with chemical differentiation in the second. A third dimension, oriented perpendicular to the two dimensional array, may then be used for further separation, or for recovery and further characterization of isolated spots.

The present invention may also find use in protein separations for forensic and medical diagnostic tools and in the separation of bioengineered proteins. Forensic analysis and diagnostics, for example, depend heavily upon differentiation between carbohydrate moieties on blood proteins and bacterial cells. Discovery of clinically useful drugs often depends on identifying interactions with specific cellular receptors, which are usually glycoproteins. Capillary electrophoresis has been extremely useful in separations of acid carbohydrates, with derivatization of the column. The present invention allows for the separation of two properties, for example glycoprotein size and carbohydrate content on a single platform, thus eliminating the need for cumbersome recovery between steps and increasing the yield of useful analyte.

Recently, techniques utilizing antibody-based affinity separations have transitioned from clinical laboratories to those for environmental monitoring. The present invention allows sequential analysis of at least two different properties, thus increasing sensitivity of analysis, with particular interest for environmental monitoring.

The present invention allows for separation of a variety of sizes of nucleic acid species, and thus, may be used for separations that are currently done by standard and pulsed-field gel electrophoresis, as well as nucleic acid sequencing. In addition, modification of the device by nucleic acid-binding molecules (e.g., proteins, drugs) allows for isolation of relevant target sequences from previously uncharacterized genomes, or for isolation of a biocomplex formed with a nucleic acid. Because separation may be multidimensional, these devices may be attached in series with a reaction chamber (for example, a PCR thermocycler) and the resultant product directly fed into the separation platform for purification and analysis in a single device.

IL may be used to create nanostructures on a variety of substrates. IL, in combination with other standard lithographic and microfabrication methodologies, may be used to create a variety of nanostructures that may be modified in many ways to produce tools for separation of relevant biomolecules. These have advantages over contemporary molecular separation systems because they exhibit superior performance (resolution, sensitivity, dynamic range, applicability, reproducibility), may be parallel-produced at relatively low cost, and are extremely flexible in terms of chemical modifications. They have defined features that may be reproducibly made, enable flexible and complex separation, and may be used with existing bioseparation and detection strategies.

Supported and Suspended Lipid Bilayers on Nanotextured Surfaces

An additional aspect of the present invention is the use of defined lithographic nanostructures to suspend or support lipid bilayers and hybrid lipid bilayers as a separation platform for membrane-associated biomolecules. This invention expands upon previous methods for (1) incorporating lipid bilayers and nanostructured surfaces for separation techniques, and (2) creating lipid bilayers in which regions of the lipid bilayers are freely suspended or supported between two aqueous reservoirs. Specifically, the present invention utilizes suspended or supported lipid bilayer architecture in the separation of transmembrane molecules.

FIG. 9 shows lipid bilayer 902 suspended on nanostructure 904. The dimensions of nanotroughs 906 are such that lipid bilayer 902 may be suspended on nanostructure 904 over the nanotrough, allowing for domains of biomolecules 908 exterior to the membrane to segregate into these troughs for separation. These structures are made by spontaneous assembly of lipid bilayers from lipid micelles on a hydrophilic surface. Transmembrane proteins and other biomolecules may be incorporated either during the formation of the micelles or formation of the membrane through fusion of micelles incorporating them or membrane ghosts. Certain membrane proteins are also capable of self-directed insertion into the membrane and these may be incorporated by direct insertion into the membrane.

FIGS. 10, 11 and 12 show various bilayers that may be associated with a particular nanostructure according to embodiments of the present invention. FIG. 10 shows a generic bilayer 1002 suspended on nanostructure 1004 over nanotroughs 1006. FIG. 11 shows a suspended lipid/self-assembled monolayer hybrid bilayer 1102 on nanostructure 1104 having nanotroughs 1106. This bilayer type of structure forms spontaneously when a monolayer containing hydrocarbon-like chains are present on the nanostructures. In this configuration, fluidity of the lower leaflets in the supported region is lost, as that leaflet is fixed. Transmembrane proteins and other membrane biomolecules are expected to move preferentially in those areas with greatest total membrane fluidity, i.e. in the troughs. It is also anticipated by the present invention that given formation conditions, e.g. size and curvature of the forming micelles in relation to the nanoarchitecture, that one may also achieve coverage of the bilayers over the entire surface, or over selected surfaces of the nanosupport. An example is represented in FIG. 12, which shows bilayer 1202 supported in nanotroughs 1206 in nanostructure 1204. This sort of structure may be achieved through selective modification of the tops of the nanostructures such that they would not support bilayer formation (e.g., hydrophobic modification) and through use of micelles that are smaller than the diameter of the nanotrough.

Of particular interest are nanofabricated arrays of structures that exhibit a gradient in their capacity to transport molecules. The reason being that such gradients allow for separation matrices that eliminate the requirement for detergent solubilization, and thus denaturation, of transmembrane biomolecules prior to separation, which is the current state of the art. Such gradient structures allow molecular species to be driven in the direction of the gradient, thereby separating the molecules based on their tendency to traverse the gradient. Molecular species may be driven across the gradient by forces such as electrophoresis, externally-applied pressure, capillarity, diffusion, and osmosis. Depending on the desired means of separation, several modifications of the nanostructured support that will enhance separation within the supported or suspended bilayer are envisioned. These include, but are not limited to chemical modifications, such as changes in hydrophobicity, charge, or dipole moment which will allow interactions with protein domains exterior to the bilayer, modification with ligands or other biomolecules that have the potential for interacting with a target class of membrane proteins, and other modifications that end users will deem necessary to base separations on membrane protein function.

Two relevant methods for fabricating suspended lipid bilayers have been reported: (1) suspending small unilamellar vesicles that are made and applied directly to an unmodified Si surface, and (2) generating large unilamellar vesicles with direct pipetting of these structures onto a surface. See, Groves, J. T., Wulfing, C., and Boxer, S. G., Electrical manipulation of glycan phosphatidyl inositol tethered proteins in planar supported bilayers, Biophysical Journal, 71: 2716-2723 (1996), and Menger, F. M., and Angelova, M. I., Accounts of Chemical Research, 31: 789-797 (1999), the entire contents and disclosures of which are hereby incorporated by reference. Preliminary studies included forming suspended lipid bilayers to examine their applicability in the present invention.

Since the electrophoretic mobility of transmembrane molecules across suspended lipid bilayers depends on (1) the molecule's mass to charge ratio, and (2) the size of the extramembrane domains relative to the corrugated apertures in the nanostructured support, it is necessary to fabricate a device that allows for preferential movement of molecules. An embodiment of the present invention suspends lipid bilayer membranes over a series of small gaps, approximately 100 nm in size, and utilizes the entire supported membrane as a separation and analysis platform. The small sizes of the gaps between features allows the lipid bilayer membrane to be suspended over the gaps, which allows for preferential movement of membrane phospholipids, transmembrane proteins, and other lipophilic biomolecules, and their complexes. More specifically, the relative fluidity of the lower leaflet of the lipid bilayer in the suspended regions, and resultant lack of steric hindrance of extramembrane protein domains, results in greater mobility of transmembrane molecules. Furthermore, by making the aperture size on the order of the molecular size of the transmembrane molecules, separations may be based on molecular filtering mechanisms in addition to electrophoretic mobility. Because the areas scanning the gaps may be supported on the underside by aqueous media, more room may also be available for intercellular domains. In addition, biophysical studies both of interactions between extra and intercellular domains of a single protein, and/or of interactions between intercellular domains of proteins within the same membrane are provided by the present invention. Thus, suspended lipid bilayer membranes offer several advantages over the current state of the art, particularly in regard to the separation and concentration of transmembrane proteins.

In a modification of the suspended lipid bilayer model, alkane-chain terminated self-assembled monolayers may be formed on the top surfaces of the nanostructured surfaces, either by silane modification of Si substrates or ω-substitued ω-substituted alkanethiols on, for example, gold. It is anticipated that these structures may provide even greater mobility of lipophilic biomolecules in supported and non-supported regions of the lipid bilayer membrane due to the immobility of the chemically fixed lower leaflet in the hybrid region.

Several nanotextured surfaces have also been explored. IL may produce a variety of features, including posts and grooves, in nearly infinite combinations of types and arrangements. Such features may be arranged in a regular array, thus mimicking standard gels, with the features either shaped or arranged in an asymmetric manner, or as semidiscontinuous, or chirped, arrays that vary in their size and/or separation distance along the direction of separation. Furthermore, a combination of grooves and/or posts may be arranged to achieve configurations that allow for two-dimensional separations. The present invention may be used for separation of membranes from osmotically disrupted cells (cell ghosts). This is particularly significant because no previous isolation of membrane-associated biomolecules is necessary, thus preserving the biomolecules' native conformations and complexes.

Although the present invention is primarily concerned with the structures described above, the nanostructured surfaces and lipid bilayer membranes may be combined in such a way to modify only the tops of the features, the lower surface of the nanostructured surface, the sides of the features, or any combination thereof. In addition, lipid bilayer membranes containing different molecules, or derived from different organelles within a cell, may be patterned on the nanostructured surface, thereby conferring a certain level of selectivity within the membrane itself, either due to innate properties of the molecules or the presence of interactive biomolecules within a region of the pattern. Thus, the present invention may be utilized in several manners to facilitate the study of biomolecules.

For instance, the nanostructured surfaces supporting lipid bilayer membranes may be utilized in biophysics to study membrane components. Because, within the suspended regions, neither leaflet of the membrane may be immobilized on the surface, total membrane fluidity may be increased, thus allowing for greater mobility of embedded biomolecules and creating an experimental milieu more closely replicating that found in the cell. Furthermore, interactions between cytoplasmic and extracellular domains may be more easily studied.

In addition, the present device shows promise as a biosensor device. Because the structure allows for proper orientation of the intercellular domains of transmembrane proteins, natural or engineered receptor proteins may take advantage of naturally occurring transduction mechanisms to facilitate signal transduction.

The present invention may further be useful in purification. The nanostructured lipid bilayer device may provide a unique platform on which to purify lipophilic membrane biomolecules. Because the components may be applied from membrane cell ghosts or in lipid micelles, the need for harsh and possibly denaturing detergent extraction may be unnecessary. In addition, complexes of associated proteins may be purified intact, thereby improving the study of pharmaceutical agents.

The present device may also be useful in the crystallization of membrane proteins to provide more pertinent information as to the structure and function of the proteins. The nanostructured lipid bilayer device may be manufactured to produce a gradient of features so that the protein in question aggregates at a single band in the device, thereby accumulating at the critical concentration.

Finally, the present invention may allow for greater flexibility in screening potential pharmaceutical agents. The nanostructured lipid bilayer device may facilitate observation of interactions between target transmembrane molecules and potential therapeutic agents within a defined membrane milieu, as well as allow for in vitro study of the resultant interactions between the drug-bound receptor and other components within the target complexes.

The present invention allows for unprecedented advances in the study of biomembranes and their associated molecules. The fact that membrane associated biomolecules may be applied to the present device, either via cell ghosts or vesicles, without first isolating them in aqueous media using detergent solubilization means that native configurations, associations and, thus, functionality may be preserved.

Design and construction of microscale electrophoresis cells incorporated much of the characteristics of the present invention into a compact system. The cell preferably has the following characteristics: (1) electrochemical current and fluid flow is restricted to occur only through the separation matrix; (2) loading and stacking functions are included; (3) monitoring of mobility and biomolecular detection is possible (e.g., through fluorescence imaging); and (4) for certain applications, separated compounds are recoverable. Simple methods have been used for incorporating nanostructured silicon/silica chips into electrophoresis cells that satisfy criteria (1-3) above. For example, simple methods of rapid prototyping of elastomeric gasket materials have been used.

Supported phospholipid bilayers (SPBs) of egg phosphatidyl choline (Egg PC) were formed by vesicle fusion on nanostructured silicon wafers containing troughs −180 nm in width on a 360 nm pitch. An intercalating dye was introduced, and the membranes were imaged by scanning laser microscopy. The resultant fluorescence micrographs indicated that the SPBs formed uniformly over the surface and simple FRAP measurements indicated that the bilayers were fluid and that recovery of fluorescence was preferentially in the direction parallel to the nanotroughs.

Transmembrane or membrane associated proteins may be incorporated into an SPB, from incorporation in the vesicle stage, insertion on the membrane or through incorporation of cell ghosts (i.e., intact membranes isolated from cells or organelles). The architecture and/or chemistry of the underlying nanotextured support would be then used to guide the movement of membrane proteins through the supported or suspended bilayer, either by size exclusion of the trough over which the membrane is supported, or by chemical interactions with modifications on the nanostructured support.

Although the present invention has been fully described in conjunction with the preferred embodiment thereof with reference to the accompanying drawings, it is to be understood that various changes and modifications may be apparent to those skilled in the art. Such changes and modifications are to be understood as included within the scope of the present invention as defined by the appended claims, unless they depart therefrom.

Brueck, Steven R. J., Lopez, Gabriel P., Ista, Linnea K.

Patent Priority Assignee Title
10081014, Sep 27 2002 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
10107726, Mar 16 2016 CellMax, Ltd.; CellMax, Ltd Collection of suspended cells using a transferable membrane
10112198, Aug 26 2014 Academia Sinica Collector architecture layout design
10495644, Apr 01 2014 Academia Sinica Methods and systems for cancer diagnosis and prognosis
10605708, Mar 16 2016 CellMax, Ltd Collection of suspended cells using a transferable membrane
11052392, Sep 27 2002 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
11674958, Jun 29 2011 Academia Sinica Capture, purification, and release of biological substances using a surface coating
8372579, Sep 27 2002 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
8961764, Oct 15 2010 ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC Micro fluidic optic design
9067207, Jun 04 2009 ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC Optical approach for microfluidic DNA electrophoresis detection
9322054, Feb 22 2012 ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC Microfluidic cartridge
9541480, Jun 29 2011 Academia Sinica Capture, purification, and release of biological substances using a surface coating
9649631, Jun 04 2009 ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC Multiple-sample microfluidic chip for DNA analysis
9656261, Jun 04 2009 ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC DNA analyzer
9988676, Feb 22 2012 ABACUS INNOVATIONS TECHNOLOGY, INC ; LEIDOS INNOVATIONS TECHNOLOGY, INC Microfluidic cartridge
Patent Priority Assignee Title
3855133,
3906929,
4190535, Feb 27 1978 BECTON DICKINSON AND COMPANY, A CORP OF NEW JERSEY Means for separating lymphocytes and monocytes from anticoagulated blood
4737268, Mar 18 1986 University of Utah Thin channel split flow continuous equilibrium process and apparatus for particle fractionation
4801380, Dec 23 1987 The Texas A&M University System Method of producing a silicon film with micropores
4814082, Oct 20 1986 Memtec America Corporation Ultrafiltration thin film membranes
4814088, Aug 28 1985 National Research Council of Canada Method for the molecular filtration of predominantly aliphatic hydrocarbon liquids
4902424, Oct 26 1986 Memtec America Corporation Ultrafiltration thin film membranes
4906439, Mar 25 1986 Behringwerke AG Biological diagnostic device and method of use
4915839, Mar 15 1984 Cuno, Incorporated Process for surface modifying a microporous membrane
4916110, Nov 01 1988 W L GORE & ASSOCIATES, INC Microporous catalytic material and support structure
4935141, Aug 31 1987 Gambro Dialysatoren GmbH Selectively permeable asymmetric membranes suitable for use in hemodialysis and processes for manufacturing such membranes
4969998, Apr 23 1984 W L GORE & ASSOCIATES, INC Composite semipermeable membrane
4971904, Jun 26 1987 E I DU PONT DE NEMOURS AND COMPANY, WILMINGTON, DE A CORP OF DE Heterogeneous immunoassay
4977078, Dec 22 1987 Olympus Optical Co., Ltd. Plate substrate immunoassay device and method for performing a multi-test immunoassay on a specimen
5013337, Dec 06 1988 UOP Process for separating a mixture of molecular species using crystalline microporous metal sulfide compositions
5019263, Jun 05 1990 Mobil Oil Corp. Membrane composed of a pure molecular sieve
5130025, Apr 20 1978 Unisearch Limited Membrane separation and purification of compounds
5131998, Nov 13 1990 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, THE, CHAPEL HILL, COUNTY OF ORANGE, NC A CONSTITUENT INSTITUTION OF NC Two-dimensional high-performance liquid chromatography/capillary electrophoresis
5145584, Dec 05 1990 Allied-Signal Inc.; ALLIED-SIGNAL INC , A CORPORATION OF DELAWARE Processes for using a thin film composite ultrafiltration membrane
5147606, Aug 06 1990 Miles Inc. Self-metering fluid analysis device
5193688, Dec 08 1989 University of Utah Method and apparatus for hydrodynamic relaxation and sample concentration NIN field-flow fraction using permeable wall elements
5204239, Jan 09 1990 YEDA RESEARCH AND DEVELOPMENT CO LTD Biosensors including lipid bilayer doped with ion channels anchored to a recording electrode by bridging molecules
5266207, Apr 30 1991 TECHSEP Composite nanofiltration membrane
5296375, May 01 1992 Trustees of the University of Pennsylvania Mesoscale sperm handling devices
5304487, May 01 1992 TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, A CORP OF PA Fluid handling in mesoscale analytical devices
5427663, Jun 08 1993 BTG INTERNATIONAL INC Microlithographic array for macromolecule and cell fractionation
5427946, May 01 1992 Trustees of the University of Pennsylvania Mesoscale sperm handling devices
5474675, Nov 17 1988 Herco-CFF ChiralFlow Filtertechnik GmbH Filter separator for separating a composite fluid
5500071, Oct 19 1994 Agilent Technologies Inc Miniaturized planar columns in novel support media for liquid phase analysis
5541072, Apr 18 1994 Veridex, LLC Method for magnetic separation featuring magnetic particles in a multi-phase system
5587070, Nov 06 1990 HAEMONETICS PUERTO RICO, LLC System for processing biological fluid
5622831, Sep 26 1990 Janssen Diagnostics, LLC Methods and devices for manipulation of magnetically collected material
5637458, Jul 20 1994 Sios, Inc. Apparatus and method for the detection and assay of organic molecules
5639669, Jun 07 1995 Separation of fetal cells from maternal blood
5646048, Jul 24 1995 Agilent Technologies Inc Microcolumnar analytical apparatus with microcolumnar flow gating interface and method of using the apparatus
5674592, May 04 1995 Minnesota Mining and Manufacturing Company Functionalized nanostructured films
5707799, Sep 30 1994 Abbott Laboratories Devices and methods utilizing arrays of structures for analyte capture
5709943, May 04 1995 Minnesota Mining and Manufacturing Company Biological adsorption supports
5715946, Jun 07 1995 Method and apparatus for sorting particles suspended in a fluid
5716527, Jul 08 1994 EXXON RESEARCH & ENGINEERING CO Zeolite membrane with a selectivity enhancing coating
5728457, Sep 30 1994 Cornell Research Foundation, Inc. Porous polymeric material with gradients
5736342, Sep 21 1993 Washington State University Research Foundation Biosensor for detecting the presence of chosen analytes
5750339, Nov 30 1994 Thomas Jefferson University Methods for identifying fetal cells
5753014, Nov 12 1993 Membrane filter and a method of manufacturing the same as well as a membrane
5770029, Jul 30 1996 Monogram Biosciences, Inc Integrated electrophoretic microdevices
5798042, Mar 07 1994 CALIFORNIA, THE UNIVERSITY OF, REGENTS OF, THE Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
5837115, Jun 08 1993 BTG INTERNATIONAL INC Microlithographic array for macromolecule and cell fractionation
5843767, Oct 28 1993 UT-Battelle, LLC Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions
5858188, Feb 28 1990 Monogram Biosciences, Inc Acrylic microchannels and their use in electrophoretic applications
5858195, Aug 01 1994 Lockheed Martin Energy Research Corporation Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis
5866345, May 01 1992 The Trustees of the University of Pennsylvania Apparatus for the detection of an analyte utilizing mesoscale flow systems
5871650, Jul 08 1994 EXXON RESEARCH & ENGINEERING CO Supported zeolite membranes with controlled crystal width and preferred orientation grown on a growth enhancing layer
5876830, Sep 08 1995 Board of Regents of the University of Colorado Method of assembly of molecular-sized nets and scaffolding
5891651, Mar 29 1996 Mayo Foundation for Medical Education and Research Methods of recovering colorectal epithelial cells or fragments thereof from stool
5922591, Jun 29 1995 AFFYMETRIX, INC A DELAWARE CORPORATION Integrated nucleic acid diagnostic device
5928880, May 01 1992 Trustees of the University of Pennsylvania Mesoscale sample preparation device and systems for determination and processing of analytes
5935822, Mar 21 1995 Regents of the University of Colorado, The Product and process for membrane and soluble polypeptide segregation
5938923, Apr 15 1997 Regents of the University of California, The Microfabricated filter and capsule using a substrate sandwich
5993661, Apr 14 1997 The Research Foundation of State University of New York Macroporous or microporous filtration membrane, method of preparation and use
6007690, Jul 30 1996 Monogram Biosciences, Inc Integrated microfluidic devices
6022590, Jul 14 1994 Competitive Technologies, Inc. Stepwise formation of multilayered nanostructures from macromolecular precursors
6033546, Aug 01 1994 Lockheed Martin Energy Research Corporation Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis
6043177, Jan 21 1997 University Technology Corporation Modification of zeolite or molecular sieve membranes using atomic layer controlled chemical vapor deposition
6044981, Mar 07 1994 The Regents of the University of California Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
6051372, Sep 09 1997 Nimbus Biotechnologie GmbH Template induced patterning of surfaces and their reversible stabilization using phase transitions of the patterned material
6051517, Jan 21 1997 University Technology Corp. Modified zeolite membrane
6054034, Feb 28 1990 Monogram Biosciences, Inc Acrylic microchannels and their use in electrophoretic applications
6060415, Feb 10 1997 National Science Council Aligned molecular sieve crystals grown on anodic alumina membrane
6074827, Dec 02 1997 Monogram Biosciences, Inc Microfluidic method for nucleic acid purification and processing
6090289, Jul 08 1994 Exxon Research and Engineering Company Molecular sieves and processes for their manufacture
6100393, Mar 15 1996 Antibioticos, S.A. Process for purifying 7-substituted aminodeacetoxy-cephalosporins through the use of filtration membranes
6113794, Jan 25 1999 National Research Council of Canada Composite solvent resistant nanofiltration membranes
6113795, Nov 17 1998 KANSAS, UNIVERSITY OF, THE Process and apparatus for size selective separation of micro- and nano-particles
6132607, Feb 20 1998 FLORIDA STATE UNIVERSITY, THE System for continuous magnetic separation of components from a mixture
6143576, May 21 1992 BIOSITE, INC Non-porous diagnostic devices for the controlled movement of reagents
6156270, May 21 1992 BIOSITE, INC Diagnostic devices and apparatus for the controlled movement of reagents without membranes
6177373, Mar 14 1996 Exxon Chemicals Patents INC Procedure for preparing molecular sieve films
6187446, Mar 29 1995 LAURELL, THOMAS Carrier matrix for integrated microanalysis systems, method for the production thereof and use of the same
6190638, Jan 04 1996 Exxon Chemical Patents Inc. Molecular sieves and process for their manufacture
6197523, Nov 24 1997 LEVINE, ROBERT A ; WARDLAW, STEPHEN C Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
6200765, May 04 1998 Pacific Northwest Cancer Foundation Non-invasive methods to detect prostate cancer
6210570, Aug 21 1998 Agilent Technologies Inc Monolithic silica column
6241894, Oct 10 1997 Systemix High gradient magnetic device and method for cell separation or purification
6251691, Apr 25 1996 BIOARRAY SOLUTIONS LTD Light-controlled electrokinetic assembly of particles near surfaces
6261928, Jul 22 1997 Commissariat a l 'Energie Atomique Producing microstructures or nanostructures on a support
6264044, Apr 11 1997 3M Innovative Properties Company Reinforced, three zone microporous membrane
6265229, Mar 10 1994 SHENZHEN XINGUODU TECHNOLOGY CO , LTD Method and device for detection of specific target cells in specialized or mixed cell populations and solutions containing mixed cell populations
6277489, Dec 04 1998 Regents of the University of California, The Support for high performance affinity chromatography and other uses
6309798, May 08 1996 Studiengesellschaft Kohle mbH Lithographical process for production of nanostructures on surfaces
6315940, Nov 16 1996 Cytocentrics AG Microelement device
6329209, Jul 14 1998 ZYOMYX, INC Arrays of protein-capture agents and methods of use thereof
6344326, Jul 30 1996 Monogram Biosciences, Inc Microfluidic method for nucleic acid purification and processing
6361958, Nov 12 1999 OSMETECH TECHNOLOGY INC Biochannel assay for hybridization with biomaterial
6368871, Aug 13 1997 Cepheid Non-planar microstructures for manipulation of fluid samples
6383759, May 04 1998 GERALD P MURPHY CANCER FOUNDATION Non-invasive method to detect prostate cancer
6387290, Jun 16 1995 University of Washington Tangential flow planar microfabricated fluid filter
6432630, Sep 04 1996 Inverness Medical Switzerland GmbH Micro-flow system for particle separation and analysis
6444461, Apr 04 1997 Caliper Technologies Corp. Microfluidic devices and methods for separation
6450047, Nov 09 1998 Agilent Technologies, Inc. Device for high throughput sample processing, analysis and collection, and methods of use thereof
6454938, Sep 17 1998 GEFUS SBIC II, L P Integrated monolithic microfabricated electrospray and liquid chromatography system and method
6465225, Jun 29 1998 Evotec Technologies GmbH Method and device for manipulating particles in microsystems
6491823, Apr 03 1998 Intermolecular, Inc Targeted separation protocols for rapid characterizations of polymers
6503452, Nov 29 1996 BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE Biosensor arrays and methods
6540895, Sep 23 1997 California Institute of Technology Microfabricated cell sorter for chemical and biological materials
6570196, Mar 22 2000 MAX-PLANK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E V Lipid vesicles or lipid bilayers on chips
6576478, Jul 14 1998 ADVANCED BIOINTEGRATED TECHNOLOGIES, INC ; ZYOMYX, INC Microdevices for high-throughput screening of biomolecules
6582969, Jul 14 1998 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
6596144, May 27 1997 Purdue Research Foundation Separation columns and methods for manufacturing the improved separation columns
6596545, Jul 14 1998 ZYOMYX, INC Microdevices for screening biomolecules
6613525, Jul 30 1996 Monogram Biosciences, Inc Microfluidic apparatus and method for purification and processing
6632619, May 16 1997 ZELLCHIP TECHNOLOGIES INC Microfluidic system and methods of use
6635163, Jun 01 1999 Cornell Research Foundation, Inc. Entropic trapping and sieving of molecules
6641997, Mar 20 1998 ROCKEFELLER UNIVERSITY, THE Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
6664104, Dec 24 1998 Cepheid Device incorporating a microfluidic chip for separating analyte from a sample
6685841, Feb 14 2001 STC UNM Nanostructured devices for separation and analysis
6746503, Jan 30 2003 Lawrence Livermore National Security LLC Precision gap particle separator
6762059, Aug 13 1999 U S GENOMICS, INC Methods and apparatuses for characterization of single polymers
6783647, Oct 19 2001 UT-Battelle, LLC Microfluidic systems and methods of transport and lysis of cells and analysis of cell lysate
6794148, Jun 26 1995 Applied Biosystems, LLC High speed, automated, continuous flow, multi-dimensional molecular selection and analysis
6815664, Apr 27 2001 PROGENITY, INC Method for separation of particles
6818184, Aug 31 2000 The Regents of the University of California Capillary array and related methods
6872522, Jun 25 1996 MECKLENBURG, MICHAEL Broad specificity affinity arrays: a qualitative approach to complex sample discrimination
6878271, Sep 09 2002 CYTONOME ST, LLC Implementation of microfluidic components in a microfluidic system
6881315, Aug 03 2001 NEC Corporation Fractionating apparatus having colonies of pillars arranged in migration passage at interval and process for fabricating pillars
6893881, Sep 14 1992 NORWEGIAN RADIUM HOSPITAL RESEARCH FOUNDATION, THE Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
6911345, Jun 28 1999 California Institute of Technology Methods and apparatus for analyzing polynucleotide sequences
6913697, Feb 14 2001 STC UNM Nanostructured separation and analysis devices for biological membranes
6958245, Apr 25 1996 BIOARRAY SOLUTIONS LTD Array cytometry
6960449, Feb 10 1999 GPB Scientific, LLC Class characterization of circulating cancer cells isolated from body fluids and methods of use
7150812, Oct 23 2002 TRUSTEES OF PRINCETON UNIVERSITY, THE Method for continuous particle separation using obstacle arrays asymmetrically aligned to fields
20010036672,
20020005354,
20020058332,
20020090741,
20020108859,
20020115163,
20020115164,
20020123078,
20020123112,
20020132315,
20020132316,
20020172987,
20030072682,
20030077292,
20030159999,
20040018116,
20040072278,
20040121343,
20040144651,
20040232074,
20040245102,
20050049793,
20050092662,
20050123454,
20050142663,
20050145497,
20050164158,
20050170373,
20050170418,
20050175996,
20050191636,
20050211556,
20050236314,
20050239101,
20050244843,
20050250111,
20050250199,
20050252840,
20050262577,
20050266433,
20050282196,
20060051265,
20060060767,
20060134599,
20060160243,
20060223178,
20060252054,
20060252087,
20070026381,
20070026413,
20070026414,
20070026415,
20070026416,
20070026417,
20070026418,
20070026419,
20070026469,
20070059680,
20070059683,
20070059716,
20070059718,
20070059719,
20070059774,
20070059781,
20070099207,
DE19712309,
EP57907,
EP94193,
EP919812,
EP1221342,
EP1338894,
EP1418003,
EP1462800,
WO62931,
WO212896,
WO228523,
WO230562,
WO3000418,
WO3031938,
WO3035894,
WO3079006,
WO3085379,
WO2004004906,
WO2004015411,
WO2004024327,
WO2004029221,
WO2004037374,
WO2004056978,
WO2004113877,
WO2005043121,
WO2005047529,
WO2005049168,
WO2005058937,
WO2005068503,
WO2005084374,
WO2005085861,
WO2005108621,
WO2005109238,
WO2005121362,
WO2006078470,
WO9322053,
WO9429707,
WO9810267,
WO9944064,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jul 01 2008STC.UNM(assignment on the face of the patent)
Date Maintenance Fee Events


Date Maintenance Schedule
Mar 29 20144 years fee payment window open
Sep 29 20146 months grace period start (w surcharge)
Mar 29 2015patent expiry (for year 4)
Mar 29 20172 years to revive unintentionally abandoned end. (for year 4)
Mar 29 20188 years fee payment window open
Sep 29 20186 months grace period start (w surcharge)
Mar 29 2019patent expiry (for year 8)
Mar 29 20212 years to revive unintentionally abandoned end. (for year 8)
Mar 29 202212 years fee payment window open
Sep 29 20226 months grace period start (w surcharge)
Mar 29 2023patent expiry (for year 12)
Mar 29 20252 years to revive unintentionally abandoned end. (for year 12)